These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15244523)

  • 21. Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative Group.
    Pulsoni A; Stazi A; Cotichini R; Allione B; Cerri R; Di Bona E; Nosari AM; Pagano L; Recchia A; Ribersani M; Rocchi L; Veneri D; Visani G; Mandelli F; Mele A
    Eur J Haematol; 1998 Nov; 61(5):327-32. PubMed ID: 9855248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.
    Pollicardo N; O'Brien S; Estey EH; al-Bitar M; Pierce S; Keating M; Kantarjian HM
    Leukemia; 1996 Jan; 10(1):27-31. PubMed ID: 8558933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukemias resembling acute promyelocytic leukemia, microgranular variant.
    Nagendra S; Meyerson H; Skallerud G; Rosenthal N
    Am J Clin Pathol; 2002 Apr; 117(4):651-7. PubMed ID: 11939742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of acute promyelocytic leukemia in Italy. APL Collaborating Group.
    Avvisati G; Mele A; Stazi MA; Vegna ML; Pasquini P; Mandelli F
    Ann Oncol; 1991 Jun; 2(6):405-8. PubMed ID: 1768626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of acute promyelocytic leukaemia.
    Douer D
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):357-67. PubMed ID: 12935956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased risk of central venous catheter-associated thrombosis in acute promyelocytic leukemia: a single-institution experience.
    Grisariu S; Spectre G; Kalish Y; Gatt ME
    Eur J Haematol; 2013 May; 90(5):397-403. PubMed ID: 23414485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of bone marrow samples for discrimination of acute promyelocytic leukemia from other types of acute leukemia using the routine automated hematology analyzer.
    Jang MJ; Choi HW; Lee SY; Lee OJ; Kim HR; Shin JH; Suh SP; Ryang DW; Shin MG
    Int J Lab Hematol; 2014 Oct; 36(5):531-40. PubMed ID: 24410923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I; Rigal-Huguet F; Vekhoff A; Desablens B; Bordessoule D; Mounier C; Ferrant A; Sanz M; Fey M; Chomienne C; Chevret S; Degos L; Fenaux P;
    Leukemia; 2003 Aug; 17(8):1600-4. PubMed ID: 12886249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD34 positive-microgranular variant of acute promyelocytic leukemia in a child.
    Nargund AR; Patil GV; Raghuram CP; Venkataswamy E
    Indian J Pathol Microbiol; 2012; 55(4):574-7. PubMed ID: 23455812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia.
    Gomis F; Sanz J; Sempere A; Plumé G; Senent ML; Pérez ML; Cervera J; Moscardó F; Bolufer P; Barragán E; Martín G; Sanz MA
    Ann Hematol; 2004 Nov; 83(11):687-90. PubMed ID: 15278297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.
    Sanz MA; Montesinos P; Kim HT; Ruiz-Argüelles GJ; Undurraga MS; Uriarte MR; Martínez L; Jacomo RH; Gutiérrez-Aguirre H; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Vellenga E; Holowiecka A; González-Huerta AJ; Fernández P; De la Serna J; Brunet S; De Lisa E; González-Campos J; Ribera JM; Krsnik I; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Rego EM;
    Ann Hematol; 2015 Aug; 94(8):1347-56. PubMed ID: 25975975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients.
    Rahmé R; Thomas X; Recher C; Vey N; Delaunay J; Deconinck E; Hirsch P; Bordessoule D; Micol JB; Stamatoullas A; Mariette C; Pautas C; Bories P; Marolleau JP; Hunault-Berger M; Fegueux N; Raffoux E; Dombret H; Degos L; Fenaux P; Adès L
    Leukemia; 2014 Dec; 28(12):2422-4. PubMed ID: 25142818
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific chromosomal abnormalities in patients with acute nonlymphocytic leukemia from the Islamic Republic of Iran.
    Abolfazl M; Fatemeh I; Hamid A; Mojtaba G; Alireza MJ; Ali MM
    Asian Pac J Cancer Prev; 2006; 7(3):447-50. PubMed ID: 17059342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haplotype study of microsatellites flanking the t(15;17) breakpoint in acute promyelocytic leukemia patients from North Portugal.
    Martins S; Trigo F; Azevedo L; Silva MJ; Guimaraes JE; Amorim A
    Leukemia; 2002 Jul; 16(7):1353-7. PubMed ID: 12094260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Leukemogenesis and therapy of acute promyelocytic leukemia: from the worse to the most favorable subtype of acute myeloid leukemia].
    Korístek Z; Mayer J
    Vnitr Lek; 2008; 54(7-8):701-27. PubMed ID: 18780571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Could Acute Myeloid Leukemia Have Presented Even Worse? "Uncommon Cause of Concurrently Multivessel Thrombosis".
    Hazir KE; Simsek EC; Baldan E; Uzun HG; Bulbul H; Yarci B; Ozcan EB
    Arq Bras Cardiol; 2023 Jul; 120(8):20220808. PubMed ID: 37586004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.